Antonio Lee | Chief Executive Officer & Managing Director
MEDIPOST America | Republic Of Korea

Antonio Lee, Chief Executive Officer & Managing Director, MEDIPOST America

Dr. Antonio (Tony) Lee is the Global Head of Business Development at MEDIPOST (KOSDAQ: 078160; Seoul, Korea) and also serves as the CEO and Managing Director at MEDIPOST America Inc., a wholly-owned subsidiary of MEDIPOST. Since 2011, Tony has been involved in the commercialization and clinical development, regulatory affairs and marketing of human Umbilical Cord Blood-derived Stem Cell technology and products developed by MEDIPOST including World’s First regulatory-approved allogeneic stem cell product – CARTISTEM®.
Prior to joining MEDIPOST, Tony held research scientist positions in the field of Stem Cell Biology & Regenerative Medicine in Sydney, Australia. Tony received his Ph.D. in Developmental and Stem Cell Biology from University of Otago, New Zealand.


Phar-East Day One @ 09:40

The Macro View: What will it take for Asia’s biotech industry to really flourish?

Everyone knows it is too generic to classify all Asian countries in a single category. With the exception of China and India, the remaining part of Asia is complicated, fragmented and diversified. With growing GDPs and middle class populations, the potential of Asia’s biotech industry is undeniable in the eye of global leaders. The main question is, how can government and related stakeholders assist the biotech industry to flourish to provide more affordable, personalised medicine for its populations? How do countries move away from a “me-too” to “me-first” mentality, especially when it comes to pharma R&D?

Phar-East Day Two @ 09:30

Innovation beyond limit: How do we conquer incurable diseases and create new history

Advancement in research helps to push the limitation of treatment paradigm to attempt curing currently incurable diseases. Innovative therapeutic solutions however is often not sufficient without a strong team to help with commercialisation. In this presentation, Antonio will share about the overall landscape in Asia stem cell therapy, challenges in current landscape and opportunities ahead to achieve commercial excellence.  

back to speakers